Document is current

Article History

Received: 18 September 2024

Accepted: 13 December 2024

First Online: 29 January 2025

Declarations

:

: Matthias Augustin served as a consultant or paid speaker for clinical trials sponsored by companies that manufacture drugs used for the treatment of alopecia areata, including AbbVie, Almirall, Eli Lilly, and Pfizer, and received support for attending meetings/travel from Lilly. Maddalena Napolitano reports consulting fees from AbbVie, Lilly, LEO Pharma, Almirall, Sanofi; payment/honoraria from AbbVie, Lilly, LEO Pharma, Almirall, and Sanofi; participation on data safety monitoring/advisory boards from Lilly, Sanofi, LEO Pharma, AbbVie, and Almirall; and support for attending meetings/travel from Lilly. Rosa Izu-Belloso reports payment as an advisor for Lilly, AbbVie, Sanofi, and LEO Pharma; grant support from Lilly; support for attending meetings/travel from Lilly; and payment for speaking from Lilly. C. Elise Kleyn reports grants/contracts from Eli Lilly and the Dowager Countess Eleanor Peel Trust; consulting fees from Eli Lilly, UCB, Almirall, Janssen, and La Roche Posay; payment/honoraria from Eli Lilly, UCB, Almirall, Janssen, and La Roche Posay; and support for attending meetings/travel from UCB, for participation on industry advisory boards for Eli Lilly, UCB, Almirall, Janssen, La Roche Posay, and Celgene, and for leadership/fiduciary roles in other boards/societies/committees or advocacy groups for the Psoriasis Association, International Psoriasis Council, Psychodermatology UK, as Governor for the Northern Care Alliance, and as Visiting Professor of Bolton University. Silvia Sabatino, Susanne Grond, and Joaquin R. Otero-Asman are employees and minor shareholders of Eli Lilly and Company. Chunyuan Liu is a consultant from Tigermed-BDM Inc. working for Eli Lilly and Company. Ziad Reguiai has received consulting fees from AbbVie, Almirall, Amgen, Celgene, Celltrion, Cerave, Incyte, GSK, Janssen Cilag, La Roche Posay, LEO Pharma, Lilly, Novartis, Pfizer, Sanofi, and UCB; payment/honoraria from AbbVie, Almirall, Amgen, Avene, BMS, Celgene, GSK, Janssen-Cilag, LEO Pharma, Lilly, Medac, MSD, Novartis, La Roche Posay, Pierre Fabre Dermatologie, Pfizer, and UCB; and support for attending meetings/travel from AbbVie, Almirall, Amgen, BMS, Janssen Cilag, LEO Pharma, Lilly, Novartis, Pfizer, Sanofi, and UCB. Toshifumi Nomura reports payment/honoraria from Eli Lilly, Sanofi, AbbVie, Pfizer, LEO Pharma, Torii, Ohtsuka, and Maruho.

: All studies included in this analysis were conducted in accordance with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all eligible participants before undergoing study-related procedures.